SPPI News and Press, Spectrum Pharmaceuticals Inc. From 09/09/22

Whether you’re a seasoned trader making money with penny stocks or just getting your feet wet, 2022 has been a wild year for all levels of experience. This week, particularly, marks somewhat of the calm before the storm as September is likely to heat up even more. Stock Market Go...

Spectrum Pharmaceuticals ( NASDAQ: SPPI ) stock jumped 10.4% afterhours on Friday after the U.S. Food and Drug Administration approved its Rolvedon injection . The injection is used to treat chemotherapy-induced neutropenia (abnormally low count of a type of neutr...

First novel Long-Acting GCSF (LA-GCSF) product approved in over 20 years ROLVEDON ™ developed using proprietary LAPSCOVERY ™ technology with a differentiated molecular structure and proven safety and efficacy profile Commercial team ready ...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced a poster presentation titled: High Activity of Poziotinib in G778_P780dup HER2 Exon 20 Insertion Mutations in Non-Small Lung Cancer (NSCLC). The p...

SPECTRUM PHARMACEUTICALS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Spectrum Pharmaceuticals, Inc. - SPPI SPECTRUM PHARMACEUTICALS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERA...

We are circling back on a small biopharma named Spectrum Pharmaceuticals for the first time in a year and a half today. Spectrum has turned into a soap opera since then with two departures from the C-Suite, a CRL, and a significant workforce reduction. However, the company still i...

Cedar Realty Trust ( CDR ) +204% . Codiak BioSciences ( CDAK ) +33% . Curis ( CRIS ) +32% Lifts Partial Clinical Hold on the TakeAim Lymphoma Study of Emavusertib. Bruush Oral Care ( BRSH ) +25% . Wolfspeed ( WOLF ) +21% Q2 ear...

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI). On August 6, 2021, the Company dis...

Image source: The Motley Fool. Spectrum Pharmaceuticals (NASDAQ: SPPI) Q2 2022 Earnings Call Aug 11, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Spectrum Pharmaceuticals (SPPI) Q2 2022 Earnings Call Transcript ...

Spectrum Pharma ( NASDAQ: SPPI ) is trading ~9% higher after the company said the U.S. Food and Drug Administration completes re-inspection of drug substance manufacturing facility for eflapegrastim to treat chemotherapy-induced neutropenia. "The completion o...